共 50 条
- [1] FDA advisory committee meeting outcomes [J]. Nature Reviews Drug Discovery, 2012, 11 : 513 - 514
- [2] Preparing for An FDA Advisory Committee Meeting [J]. Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 35 - 41
- [3] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (10): : 1288 - 1289
- [4] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (05): : 595 - 596
- [5] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (09): : 1124 - 1125
- [7] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (04): : 450 - 451
- [8] The rosiglitazone story - Lessons from an FDA advisory committee meeting [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09): : 844 - 846
- [9] Advisory committee meeting [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1679 - 1679
- [10] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - EXPANDED ROLE FOR COMMITTEE MEMBERS - GUIDELINES ON ANALGESICS [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (12): : 1619 - 1619